Takeda Pharmaceutical Company Limited Changes In Fair Value Of Financial Assets Related Credit Derivatives Or Similar Instruments
Takeda Pharmaceutical Company Limited (TKPHF) reported Changes In Fair Value Of Financial Assets Related Credit Derivatives Or Similar Instruments of -JPY 22.59 billion for the 12-month period ending 2022-03-31, per its 20-F filed 2022-06-29.
Discontinued › Notes › Derivative Instruments and Hedging Activities
ifrs-full:ChangesInFairValueOfFinancialAssetsRelatedCreditDerivativesOrSimilarInstruments · last filed 2022-06-29
| Period end | Changes In Fair Value Of Financial Assets Related Credit Derivatives Or Similar Instruments 12 month |
|---|---|
| 2022-03-31 | -22.59B JPY 20-F · filed 2022-06-29 |
| 2021-03-31 | 0.00 JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | -1.79B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | -11.37B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 0.00 JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | -5.43B JPY 20-F · filed 2019-06-27 |